Every answer we’ve verified
Each cell links to the insurer’s own published wording, quoted, with the date we read it. Empty cells are combinations we have not checked rather than answers of no.
32 answers · 8 insurers · 4 brands
| Insurer | Mounjaro | Ozempic | Wegovy | Zepbound |
|---|---|---|---|---|
Aetna | NoAug 28 | NoAug 20 | DependsAug 20 | ExcludedAug 20 |
Anthem | NoAug 28 | NoAug 28 | DependsAug 28 | DependsAug 28 |
Blue Cross Blue Shield | NoAug 28 | NoAug 20 | DependsAug 20 | DependsAug 20 |
Cigna | NoAug 28 | NoAug 20 | DependsAug 20 | DependsAug 20 |
Humana | NoAug 28 | NoAug 28 | NoAug 28 | NoAug 28 |
Kaiser Permanente | NoAug 28 | NoAug 28 | DependsAug 28 | DependsAug 28 |
TRICARE | NoAug 28 | NoAug 28 | YesAug 28 | YesAug 28 |
UnitedHealthcare | NoAug 28 | NoAug 20 | DependsAug 20 | DependsAug 20 |
Covered on published plansDepends on your planGenerally not coveredExcluded from standard formulary
Verdicts describe weight-loss use. Almost every plan here treats type 2 diabetes differently and more generously, which each sheet sets out separately.
Your insurer probably isn’t the one deciding
The formulary, which is the list that says whether a drug is preferred, excluded or behind step therapy, is usually run by a pharmacy benefit manager rather than by the insurer whose name is on your card. When you read that a plan “dropped Zepbound,” this is the company that dropped it. Knowing yours is often more useful than knowing your insurer, because plans sharing a benefit manager tend to share an answer.
CVS Caremark
runs the formulary for Aetna
CarelonRx
runs the formulary for Anthem
Express Scripts
runs the formulary for Cigna, TRICARE
Optum Rx
runs the formulary for UnitedHealthcare
Two names are missing on purpose. Blue Cross Blue Shield is around 33 independent licensees running different benefit managers, and Kaiser Permanente is an integrated system with regional formularies and no outside manager at all. In both cases one national answer would be wrong, which is why those sheets say so instead.
The three ways people actually pay
Plan covers it
A brand prescription plus the manufacturer savings card. Worth being precise: the card takes up to $100 a month off your copay rather than setting your price to $25, so you land on the advertised figure only if your copay is roughly $125 or less. Prior authorization is usually required either way.
Medicare
Since July 2026, covered brand GLP-1s run about $50/mo through Medicare drug plans. Requires Medicare and plan coverage; ask your prescriber. Manufacturer savings cards exclude government beneficiaries, so on Medicare, Medicaid or TRICARE For Life the card is not an option and the Bridge is the thing to ask for by name.
Plan says no
Cash-pay is the fallback, and it’s the number we track all day. Cheapest program right now: $69/mo (Embody), covering both semaglutide and tirzepatide.
Compare every program on the boardIf you want the money detail
Coverage answers whether. These answer what it costs you, and what to do when the answer is no.







